Adverum Biotechnologies Inc ADVM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:30 AM EST
0.6958quote price arrow up+0.0023 (+0.33%)
Volume
952,762
52 week range
0.53 - 1.82
Loading...
  • Open0.71
  • Day High0.71
  • Day Low0.6823
  • Prev Close0.6935
  • 52 Week High1.82
  • 52 Week High Date07/14/22
  • 52 Week Low0.53
  • 52 Week Low Date12/27/22

Key Stats

  • Market Cap69.39M
  • Shares Out99.73M
  • 10 Day Average Volume0.38M
  • Dividend-
  • Dividend Yield-
  • Beta0.81
  • YTD % Change19.07

KEY STATS

  • Open0.71
  • Day High0.71
  • Day Low0.6823
  • Prev Close0.6935
  • 52 Week High1.82
  • 52 Week High Date07/14/22
  • 52 Week Low0.53
  • 52 Week Low Date12/27/22
  • Market Cap69.39M
  • Shares Out99.73M
  • 10 Day Average Volume0.38M
  • Dividend-
  • Dividend Yield-
  • Beta0.81
  • YTD % Change19.07

RATIOS/PROFITABILITY

  • EPS (TTM)-1.58
  • P/E (TTM)-0.44
  • Fwd P/E (NTM)-0.51
  • EBITDA (TTM)-149.476M
  • ROE (TTM)-56.36%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-1,940.53%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date03/14/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Adverum Biotechnologies Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company, which targets unmet medical needs in ocular and rare diseases. The Company develops gene therapy product candidates. Its lead product candidate, ADVM-022, is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable levels of aflibercept associated with a sustained treatment response, reducing the treatment burden and fluctuations in macular fluid...
Patrick Machado J.D.
Independent Chairman of the Board
Laurent Fischer M.D.
President, Chief Executive Officer, Director
Kishor Soparkar J.D.
Chief Operating Officer
Linda Rubinstein
Chief Financial Officer
John Rakow
General Counsel
Address
100 Cardinal Way
Redwood City, CA
94063
United States

Top Peers

SYMBOLLASTCHG%CHG
SPRB
Spruce Biosciences Inc
2.97+0.25+9.35%
LIFE
aTyr Pharma Inc
2.30+0.05+2.28%
IMUX
Immunic Inc
2.38+0.28+13.33%
JSPR
Jasper Therapeutics Inc
1.68-0.08-4.55%
ANEB
Anebulo Pharmaceuticals Inc
2.51+0.11+4.59%